RE:Concordia Top Picks from Ryan ModestoIt is important to underline also that only 10% of sales is subject to U.S. government reimbursement plans so the U.S. regulatory risk is minimal. I know a thing or two about companies going out of business. This is the exact opposite. CXR is a cash generating machine with great growth potential. In 12 months, those who haven't stuck around or sold will be kicking themselves.